Physician profile
Daniel Walsh
NPI 1679276489
$1,533.95
in general payments reported to CMS, 2019-2025
7 companies · $583 in 2025
The $583 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $386 · 2024: $564 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.36 |
| Education | $135.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $678.83 | 2023-2025 | Na, Acf, Conduit |
| Stryker Corporation | $536.33 | 2023-2025 | Mako, Gamma, Pangea |
| Next Science LLC | $144.54 | 2025 | Blastx, Xperience |
| Medical Device Business Services, INC. | $107.07 | 2023-2025 | Na, Attune |
| Ethicon US, LLC | $31.10 | 2023 | Stratafix |
| Solventum Corporation | $22.96 | 2024 | V.A.C. Veraflo, Bair Hugger, Prevena Restor Bellaform |
| Harrow Eye, LLC | $13.12 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.